SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-199179
Filing Date
2014-05-14
Accepted
2014-05-14 16:43:15
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d702406d10q.htm 10-Q 246306
2 EX-31.1 d702406dex311.htm EX-31.1 5956
3 EX-31.2 d702406dex312.htm EX-31.2 6084
4 EX-32 d702406dex32.htm EX-32 4425
  Complete submission text file 0001193125-14-199179.txt   1855308

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bgmd-20140331.xml EX-101.INS 132959
6 XBRL TAXONOMY EXTENSION SCHEMA bgmd-20140331.xsd EX-101.SCH 25317
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bgmd-20140331_cal.xml EX-101.CAL 36699
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bgmd-20140331_def.xml EX-101.DEF 137117
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bgmd-20140331_lab.xml EX-101.LAB 184256
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bgmd-20140331_pre.xml EX-101.PRE 159895
Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33827 | Film No.: 14842103
SIC: 2835 In Vitro & In Vivo Diagnostic Substances